Tobi Podhaler

This page shows the latest Tobi Podhaler news and features for those working in and with pharma, biotech and healthcare.

NICE backs Novartis/ ThromboGenics’ eye drug

ranibizumab). Novartis has also won the cost-effectiveness watchdog's backing in 2013 for the Tobi Podhaler (tobramycin), a treatment for cystic fibrosis.

Latest news

NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest

The limited recommendation takes into account that the Tobi Podhaler and Colobreathe are dry powder versions of already available nebulised products. ... form. The Tobi Podhaler should only be used in cystic fibrosis patients for whom nebulised
NICE backs two cystic fibrosis treatments for NHS use

NICE backs two cystic fibrosis treatments for NHS use. Novartis’ Tobi Podhaler and Forest’ s Colobreathe recommended at discounted price. ... Novartis' Tobi Podhaler and Forest Laboratories' Colobreathe have both received backing for use in the NHS
NICE backs Novartis’ Tobi Podhaler in cystic fibrosis

NICE backs Novartis’ Tobi Podhaler in cystic fibrosis. But draft guidance doesn't recommend Forest’ s Colobreathe. ... In addition, the Tobi Podhaler should only be available for patients unable to use nebulised colistimethate, or for whom nebulised
FDA panel backs Novartis' updated cystic fibrosis drug

Novartis' current tobramycin product TOBI has been the standard of care of this infection in CF since it was launched in 1997, but is delivered using a nebuliser machine which is ... The new product is already approved in the EU and Canada, where it is

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Latest Intelligence

Deal Watch October 2018

Mylan has enhanced its respiratory portfolio with the acquisition of Novartis’s TOBI Podhaler® and TOBI® solution, both products for treating Pseudomonas aeruginosa infections in cystic fibrosis patients. ... Licensing &. research. collaboration.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Director development role to Business Director, H...: Excellent package

Account Manager / Account Director: Competative

Account Director: Excellent benefits

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

New Business Director - PR: Competitive Salary and benefits

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Account Director: £48, 000 - £60, 000

Consultant Health Economics - London / Oxford: Negotiable

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Associate Medical Director: Excellent PTO, bonus and 401k package

Senior Medical Writer (Remote Working): Competitive Salary Offered

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Medical/ Scientific Director: Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Project / Account Manager (Medical Education): Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Account Executive, London, Medical Communications: Excellent package

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Subscribe to our email news alerts

PMHub

Add my company

Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...